Steadfast Medishield Private Limited

Pharmaceutical trading company with diverse product portfolio and ISO certification, established in 2008.

2008 | Delhi (India) | Active
Last Updated: December 23, 2024

Steadfast Medishield Profile

Key Indicators

  • Authorised Capital ₹ 7.50 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 16 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 62.85 Cr
  • Satisfied Charges ₹ 1.00 Cr
  • Revenue Growth 16.10%
  • Profit Growth 25.45%
  • Ebitda -29.94%
  • Net Worth 36.13%
  • Total Assets 89.35%

About Steadfast Medishield

Steadfast Medishield Private Limited (SMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 October 2008 and has a history of 16 years and four months. Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 5.00 M.

The company currently has active open charges totaling ₹62.85 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

Aman Puri, Leena Puri, and Yogesh Puri serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    steadfast.co.in

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74900DL2008PTC184339

  • Company No.

    184339

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    20 Oct 2008

  • Date of AGM

    26 Aug 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Steadfast Medishield Private Limited offer?

Steadfast Medishield Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Immunosuppressive Drugs, Anti Infective Drugs & Medicines, Antiviral Drugs, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Vitamin Tablets & Capsules, Weight Gain Nutrition, Whey Protein, Digestive System Drugs & Medicines.

Who are the key members and board of directors at Steadfast Medishield?

Board Members (3)

NameDesignationAppointment DateStatus
Aman Puri Country flag representing In Director 05-May-2017Current
Leena Puri Country flag representing In Director 20-Oct-2008Current
Yogesh Puri Country flag representing In Director 20-Oct-2008Current

Financial Performance of Steadfast Medishield.

Steadfast Medishield Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.1% increase. The company also saw a substantial improvement in profitability, with a 25.45% increase in profit. The company's net worth Soared by an impressive increase of 36.13%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
16.10%
Revenue from Operations
17.19%
Total Assets
89.35%
Profit or Loss
25.45%
Net Worth
36.13%
EBITDA
-29.94%

What is the Ownership and Shareholding Structure of Steadfast Medishield?

In 2022, Steadfast Medishield had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹628.54 M

Satisfied Charges

₹10.00 M

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 58.54 Cr
  • Others : 4.17 Cr
  • Axis Bank Limited : 0.14 Cr

Latest Charge Details

DateLenderAmountStatus
30 Sep 2024Others₹1.27 CrOpen
05 Aug 2024Axis Bank Limited₹1.41 MOpen
02 Mar 2024Hdfc Bank Limited₹2.70 MOpen
02 Mar 2024Hdfc Bank Limited₹2.70 MOpen
20 Oct 2021Hdfc Bank Limited₹58.00 CrOpen

How Many Employees Work at Steadfast Medishield?

Steadfast Medishield has a workforce of 264 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Steadfast Medishield, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steadfast Medishield's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Steadfast Medishield

Recent activity within the organization

  • Charges

    A charge with Others amounted to Rs. 12.70 M with Charge ID 100982794 was registered on 30 Sep 2024.

    30 Sep 2024

  • Charges

    A charge with Hdfc Bank Limited of Rs. 580.00 M registered on 20 Oct 2021 with Charge ID 100495960 was modified on 04 Sep 2024.

    04 Sep 2024

  • Annual General Meeting

    Steadfast Medishield Private Limited last Annual general meeting of members was held on 26 Aug 2024 as per latest MCA records.

    26 Aug 2024

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 1.41 M with Charge ID 100966112 was registered on 05 Aug 2024.

    05 Aug 2024

  • Balance Sheet

    Steadfast Medishield Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

    31 Mar 2024

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.70 M with Charge ID 100913128 was registered on 02 Mar 2024.

    02 Mar 2024

Frequently asked questions

  • Steadfast Medishield Private Limited was incorporated on 20 Oct 2008.

  • The authorized share capital of Steadfast Medishield Private Limited is ₹ 7.50 M and paid-up capital is ₹ 5.00 M.

  • Currently 3 directors are associated with Steadfast Medishield Private Limited.

    • Aman Puri
    • Leena Puri
    • Yogesh Puri
  • As per Ministry of Corporate Affairs (Mca), the registered address of Steadfast Medishield Private Limited is 106 First Floor Anupam Plaza-I Plot No.-6, Lsc Ghazipur India, New Delhi, 110096.

  • The corporate identification number (CIN) of Steadfast Medishield Private Limited is U74900DL2008PTC184339 and the company number is 184339 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Steadfast Medishield Private Limited is https://www.steadfast.co.in

  • According to the financial reports for the fiscal year 2022, the revenue trend for Steadfast Medishield Private Limited has risen by 16.10%.

  • As Per 2022 financial reports, 264 employees are currently employed by Steadfast Medishield Private Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Steadfast Medishield Private Limited has experienced an upsurge of 36.13%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Steadfast Medishield Private Limited amount to ₹ 62.85 Cr.

  • The most recent Balance Sheet for Steadfast Medishield Private Limited was filed with the ROC on 31 Mar 2024.